Across TCGA cell cohorts, CTAGE1 mutation is significantly associated with the drug of many other genes, with 21 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible CTAGE1-associated genes across cancer lineages are VE-822, PRT062607, and CDK9_5576. Each is linked with CTAGE1 in more than 1 cancer types. Because this analysis shows association rather than direction, both CTAGE1-to-partner and partner-to-CTAGE1 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CTAGE1→partner) and Y-score (partner→CTAGE1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LARGE_INTESTINE	VE-822 →	+0.671	+2.646	.018	.047	2	2
LARGE_INTESTINE	PRT062607 →	+0.585	+2.769	.020	.040	3	1
LARGE_INTESTINE	CDK9_5576 →	+0.620	+2.710	.016	.027	3	1
LARGE_INTESTINE	Motesanib →	+0.329	+2.678	.042	.037	2	1
LARGE_INTESTINE	Nilotinib →	+0.468	+2.906	.030	.033	1	1
LARGE_INTESTINE	5-Fluorouracil →	+0.607	+2.769	.036	.040	1	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 21 associations by consensus.

Exploration

CTAGE1 survival (RNA) · tumor vs normal (RNA) · all CTAGE1 data types